DDR1 and nonpapillary renal cell carcinoma: We found that DDR gene mutations were associated with higher tumor mutational burden (TMB) (p < 0.001, Fig. 2B) and neoantigen load (p < 0.001, Fig. 2C) in Chinese ccRCC patients, which may indicate that DDR is associated with immunotherapy response in the Chinese population.